Characterization of endoscopic ultrasound fine-needle aspiration cytology by targeted next-generation sequencing and theranostic potential

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 1, 2015, Pages 37-41

  Gleeson, Ferga C ^a   Kipp, Benjamin R ^a   Kerr, Sarah E ^a   Voss, Jesse S ^a   Lazaridis, Konstantinos N ^a   Katzka, David A ^a   Levy, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endoscopic ultrasound fine needle aspiration; Individualized medicine; Malignant cytology; Targeted next generation sequencing; Theranostics

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ADRENAL METASTASIS; ASPIRATION CYTOLOGY; CANCER DIAGNOSIS; CANCER THERAPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; GASTROINTESTINAL TUMOR; GENE MUTATION; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING; NON SMALL CELL LUNG CANCER; REVIEW; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; CYTOLOGY; ENDOSCOPIC ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GASTROINTESTINAL NEOPLASMS; GENOTYPING TECHNIQUE; HIGH THROUGHPUT SEQUENCING; MOLECULAR DIAGNOSIS; PROCEDURES;

BIOPSY, FINE-NEEDLE; CYTOLOGICAL TECHNIQUES; ENDOSONOGRAPHY; GASTROINTESTINAL NEOPLASMS; GENOTYPING TECHNIQUES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 84916920201     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.10.017     Document Type: Review

References (20)

1. Gleeson F.C., Kipp B.R., Levy M.J., et al. Lung cancer adrenal gland metastasis: optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing. Cancer Cytopathol 2014, Epub ahead of print.
2. Gleeson F.C., Kipp B.R., Kerr S.E., et al. Kinase genotype analysis of gastric gastrointestinal stromal tumor cytology samples using targeted next-generation sequencing. Clin Gastroenterol Hepatol 2015, 13:202-206.
3. Bellevicine C., Vita G.D., Malapelle U., et al. Applications and limitations of oncogene mutation testing in clinical cytopathology. Semin Diagn Pathol 2013, 30:284-297.
4. Bediaga N.G., Davies M.P., Acha-Sagredo A., et al. AmicroRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. Br J Cancer 2013, 109:2404-2411.
5. Fischer A.H., Cibas E.S., Howell L.P., et al. Role of cytology in the management of non-small-cell lung cancer. JClin Oncol 2011, 29:3331-3332. author reply 3332-3333.
6. Kosmidou V., Oikonomou E., Vlassi M., et al. Tumour heterogeneity revealed by KRAS, BRAF and PIK3CA pyrosequencing: KRAS and PIK3CA intratumour mutation profile differences and their therapeutic implications. Hum Mutat 2014, 35:329-340.
7. Bedard P.L., Hansen A.R., Ratain M.J., et al. Tumour heterogeneity in the clinic. Nature 2013, 501:355-364.
8. Gerlinger M., Rowan A.J., Horswell S., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. NEngl J Med 2012, 366:883-892.
9. Marte B. Tumour heterogeneity. Nature 2013, 501:327.
10. Meacham C.E., Morrison S.J. Tumour heterogeneity and cancer cell plasticity. Nature 2013, 501:328-337.
11. Baldus S.E., Schaefer K.L., Engers R., et al. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases. Clin Cancer Res 2010, 16:790-799.
12. Longo D.L. Tumor heterogeneity and personalized medicine. NEngl J Med 2012, 366:956-957.
13. Crockford A., Jamal-Hanjani M., Hicks J., et al. Implications of intratumour heterogeneity for treatment stratification. JPathol 2014, 232:264-273.
14. Carrara S., Cangi M.G., Arcidiacono P.G., et al. Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies. Am J Gastroenterol 2011, 106:1359-1363.
15. Nodit L., McGrath K.M., Zahid M., et al. Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome. Clin Gastroenterol Hepatol 2006, 4:1474-1478.
16. Al-Haddad M., Wallace M.B. Molecular diagnostics of non-small cell lung cancer using mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Cytopathology 2006, 17:3-9.
17. Levy M.J., Oberg T.N., Campion M.B., et al. Comparison of methods to detect neoplasia in patients undergoing endoscopic ultrasound-guided fine-needle aspiration. Gastroenterology 2012, 142:1112-1121.
18. Bournet B., Pointreau A., Souque A., et al. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples. Pancreatology 2012, 12:27-34.
19. Henkes D.N., Patel S.N., Rosenkranz L.A., et al. The utility of UroVysion fluorescence in situ hybridization in pancreatic fine-needle aspiration samples directed and obtained by endoscopic ultrasonography. Arch Pathol Lab Med 2013, 137:64-71.
20. van Eijk R., Licht J., Schrumpf M., et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One 2011, 6:e17791.